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ABSTRACT  
 
Jennifer Lyu: Program Evaluation of a Pilot Type-1 Diabetes Nutrition Education  
Intervention at Peking University People’s Hospital in Beijing, China  
(Under the direction of Elizabeth J. Mayer-Davis) 
 
        This study is a program evaluation of a pilot nutrition education intervention at a type-1 
diabetes clinic in Peking University People’s Hospital. The study aimed to assess three measures 
of nutrition knowledge (basics of healthy diet, food labels, and carbohydrate counting) pre- and 
post-intervention using two nutrition education surveys.  The study also aimed to use quantitative 
and qualitative methods to gain patient feedback in order to inform future steps for the 
intervention. Descriptively, there was an improving trend in all three measures of nutrition 
knowledge post-intervention, however there was only statistical significance in the difference in 
scores for “Healthy Diet” and “Carbohydrate Counting” questions.  The study also found great 
variation in baseline nutrition knowledge among patients, which suggests a need for 
modifications to the intervention to better match educational resources to patient’s baseline 
knowledge. Future modifications should also include collection of HbA1c post-intervention to 
assess physiological applicability of the intervention.   
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CHAPTER I: INTRODUCTION 
 
Diabetes is a chronic disease characterized by blood glucose levels that are above normal 
due to deficiencies of insulin production or function. 1 Glucose is the key metabolic substrate for 
tissue energy production.2 In order for the human body to effectively use glucose as an energy 
source, the body must maintain blood glucose levels at optimal concentrations.3 An essential 
organ responsible for regulating glucose metabolism is the pancreas.3 The pancreas helps 
regulates glucose in two main ways: (1) it secretes enzymes responsible for the digestion of food 
and (2) it releases the endocrine hormones known as insulin and glucagon.3 Glucagon is released 
from alpha cells of the pancreas during circumstances of low blood glucose levels, such as 
during exercise or fasting. When glucagon is released, it signals the release of glucose into the 
blood from glucose stores in the body known as glycogen.3 Glycogen stores are predominantly 
located in tissues of the skeletal muscles and liver and its breakdown is known as 
glycogenolysis.3 The second hormone, insulin, is released by beta cells within the islets of 
Langerhans of the pancreas in response to high blood glucose levels typically following the 
ingestion of a meal. When insulin is released, it binds to its receptor on the cell and signals a 
cascade of reactions that leads to the phosphorylation of a serine-threonine protein kinase. This 
kinase stimulates the translocation of GLUT 4, a glucose transporter found in the heart, skeletal 
muscles, and adipocytes. GLUT 4 then moves to the cell surface and allows for glucose uptake 
allowing the body to utilize it for energy. 4,5  
Diabetes is an example of a disease that occurs when glucose metabolism is disturbed and 
the glucose is not able to be used efficiently by the body due to an inability to properly be 
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absorbed by cells. Individuals with prediabetes have elevated glucose levels that are above the 
normal ranges, but do not yet meet the criteria for diabetes.6 Diabetes and prediabetes may be 
diagnosed based on either plasma glucose or hemoglobin A1c (HbA1c) criteria. The plasma 
glucose criteria is based on either the fasting plasma glucose (FPG) or the 2-hour plasma (2-h 
PG) value during a 75-g oral glucose tolerance test (OGTT).1 See Table 1.  “Prediabetes” is 
defined by the presence of impaired fasting glucose (IFG) and/or impaired glucose tolerance 
(IGT), or HbA1c between 5.7-6.4%.1 The American Diabetes Association (ADA) recommend 
that prediabetes is seen not as a clinical entity, but rather as an increased risk for type-2 diabetes 
and cardiovascular disease (CVD).6 According to the 2017 National Diabetes Statistics Report 
published by the Centers of Disease Control and Prevention (CDC), approximately 84.1 million 
American adults – more than 1 out of 3 – have prediabetes.7 Of this total, 15-30% of people with 
pre-diabetes will develop type 2 diabetes within 5 years.7  Additionally, nearly half of adults 
aged 65 years and older had prediabetes.7 The ADA recommends that all individuals should be 
tested for prediabetes at age 45 years, and if necessary repeat testing should be performed at least 
every three years. 1 Further, prediabetes has been associated with obesity, dyslipidemia with high 
triglycerides and/or low HDL cholesterol, as well as hypertension. Thus, individuals of all ages 
who are overweight or obese (BMI ≥ 25 kg/m2 or ≥ 23 kg/m2 in Asian Americans) and/or who 
may have an additional risk for diabetes should be tested.1  
Table 1. Criteria for the Diagnosis of Diabetes and Prediabetes1,6  
 
 
Hemoglobin 
A1C (%)* 
Fasting Plasma Glucose 
(FPG)**  
2-Hr Plasma Glucose 
(OGTT)*** 
Prediabetes 5.7%-6.4% 100-125 mg/dL 140-199 mg/dL  
Diabetes ≥6.5% ≥126 mg/dL ≥ 200 mg/dL 
* = This test should be performed in a laboratory using a method that is NGSP certified and standardized to the 
DCCT assay/ **= Fasting defined as no caloric intake for at least 8 hours/ ***= Should be performed as described 
by the WHO, using a glucose load containing the equivalent of 75-g anhydrous glucose dissolved in water. 
  3 
Individuals with diabetes are typically diagnosed with one of the four major 
classifications: (1) type-1 diabetes (T1D), (2) type-2 diabetes (T2D), (3) gestational diabetes 
mellitus (GDM), and (4) specific types of diabetes caused by specific etiologies (i.e. 
monogenetic diabetes syndromes such as neonatal diabetes and maturity-onset diabetes of the 
young or MODY, and cystic fibrosis-related diabetes or CRFD).1  
T1D, often referred to as “insulin-dependent diabetes” or “juvenile onset diabetes” due to 
its tendency to develop in childhood, accounts for 5-10% of diabetes.1 T1D is due to cellular-
mediated autoimmune destruction of the pancreatic b-cell.1 As a result, this autoimmune 
destruction often leads to absolute insulin deficiency. T2D is often a result of insulin resistance 
and a progressive loss of b-cell insulin secretion frequency.1 The third classification, GDM, is 
diabetes diagnosed in the second or third trimester of pregnancy. The final classification varies 
with etiology. There are various monogenetic defects that cause b-cell dysfunction, such as 
neonatal diabetes and MODY.1 Neonatal or “congenital” diabetes occurs in infants under 6 
months of age and it can either be transient or permanent, depending on the mutation of distinct 
genes.1 Insulin gene (INS) mutations are the second most common cause of permanent neonatal 
diabetes and treatment often requires intensive insulin management. MODY often occurs by 
onset of high blood glucose levels before age 25 years, although diagnosis may occur at older 
ages.1 It is a result of impaired insulin secretion with minimal defects, or in some cases no defect 
in insulin action. MODY is inherited in autosomal dominant form with mutations in at least 13 
genes on various chromosomes.1 CRFD is the most common comorbidity in people with cystic 
fibrosis, occurring in about 20% of adolescents and 40-50% adults.1 Compared with T1D or 
T2D, CRFD is associated with worse nutritional status, inflammatory lung disease, and greater 
mortality. CRFD is mainly due to insulin insufficiency, however, genetic b-cell dysfunction and 
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insulin resistance associated with infection and inflammation may also contribute to the onset of 
this disease.1  
Diabetes requires meticulous treatment and care that involves regular blood glucose 
checking and management of insulin dosing regimens unique to each individual. The 
coordination of insulin with dietary intake is essential among people with T1D so as to maintain 
near-normal blood glucose levels and prevent micro- and macrovascular complications, 
including neuropathy, retinopathy, kidney disease, ketoacidosis, hypertension, stroke, and heart 
disease.8,9 This integration is achieved through individualized diabetes nutrition therapy, which 
typically involves one of two approaches: (1) fixed daily insulin doses matched to consistent 
carbohydrate intake with respect to time and amount or (2) flexible daily insulin doses 
accommodating variability in food intake, typically using carbohydrate counting.9 There is not a 
‘one-size-fits-all’ eating pattern for diabetes. Healthcare providers and dietitians should 
collaboratively develop eating plans with each individual with diabetes and provide ongoing 
implementation support.  
This paper specifically focuses on T1D among Chinese patients in Beijing, China. 
Further details on general T1D including pathogenesis, etiologies, complications, treatment and 
management, as well as details on T1D literature in China is provided in Chapter II: Literature 
Review.  
According to the International Diabetes Federation, in 2015, there were 415 million 
people worldwide living with diabetes.10 By 2040, this number is projected to increase to 642 
million people.10 Of this total amount, the Western Pacific region of the world accounts for the 
highest rates of diabetes with 153.2 million people living with the disease in 2015 and 214.8 
million people projected to have the disease by 2040.10 Compared to T2D, which accounts for 
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about 90% to 95% of all diagnosed cases of diabetes, T1D accounts for only about 5%. 11Reports 
on global variation in incidence, prevalence, and temporal trends in type 1 diabetes (T1D) are 
largely based on findings from large T1D registry studies, such as the World Health 
Organization Multinational Project for Childhood Diabetes (DIAMOND), EURODIAB, and the 
SEARCH for Diabetes in Youth (SEARCH) study.12  
In 2006, the DIAMOND project examined the trends in incidence of T1D (per 100,000 a 
year) from 1990 to 1999 in children aged £ 14 years from 114 populations in 57 countries. Out 
of a total of 84 million children, 43,013 cases of T1D were diagnosed, and over this time period, 
the average annual increase in incidence was 2.8%, with a slightly higher rate of 3.4% from 1995 
to 1999 compared to a rate of 2.4% from 1990 to 199412,13. These estimated trends showed 
statistically significant increases across continents (4.0% in Asia, 3.2% in Europe, and 5.3% in 
America), except in Central America and the West Indies where the trend showed a decrease of 
3.6%.12,13 The DIAMOND project concluded that such increases in incidence reports during this 
short period of time is less likely a result of genetic shifts, but rather environmental factors and 
the interactions between genes and the environment.12,13  
From 1989 to 1994, the EURODIAB Ace Study group reported 16, 362 cases of T1D in 
44 centers throughout Europe and Israel covering a population of approximately 28 million 
children.14 Similar to the DIAMOND project, the standardized annual incidence rate varied 
greatly from 3.2/100,000 person years in Macedonia to 40.2/100,000 person years in Finland.12,14 
During this time period, there was an annual increase in T1D incidence of 3.4%, and in some 
central regions of Europe, this rate has been reported to be higher.12,14 Additionally, the rates of 
increase were found to be highest in the youngest age group 0-4 years  (6.3%, 95% CI 1.5-8.5%), 
which suggests an immediate challenge to caring for T1D in a toddler, and an earlier onset of 
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T1D also implies a longer burden of disease.12 Similarly, in the United States, the most recent 
research shows an unadjusted estimated T1D incidence rate of 1.4% annually (from 19.5 cases 
per 100,000 youths per year from 2002 to 2003 to 21.7 cases per 100,000 youths per year from 
2011 to 2012, P=0.03). Further, in adjusted pairwise comparisons, the annual rate of increase 
was greater among Hispanics than among non-Hispanic whites (4.2% vs. 1.2%, P<0.001).15 
Among the Western Pacific region, an estimated 60,700 children under the age of 15 
have T1D, with approximately 10,000 newly diagnosed in 2015. Over 30,000 of these children 
are in China, supporting the evidence that China consists of the largest number of people with 
T1D in this region.9,10 Although evidence suggests the incidence of T1D in China is increasing, 
knowledge on T1D care in China is severely outdated. In China, dietitians are largely absent 
from continuing diabetes education for individuals with T1D, and few patients regularly practice 
self-monitoring of blood glucose or carbohydrate counting.9 Barriers to improving T1D care in 
China include the high cost of blood glucose strips and blood glucose meters, both of which are 
not covered by health insurance. 9 On average, one-third of an urban family’s income is spent on 
care for patients with T1D in China.9 Further, the lack of diabetes education and the common 
requirement for inpatient admission to receive diabetes education serve as major barriers. Other 
barriers include misconceptions relating to Chinese traditional medicine, time limitations of 
healthcare providers, and discrimination against individuals with T1D.9  
These barriers contribute to the reason why China continues to lag behind the United 
States and Europe in T1D care and further pushes the need for more research into what specific 
needs T1D patients in China are lacking currently in order to best formulate effective resolutions 
to improve treatment and management. Further effective patient-provider interactions are critical 
to fostering effective self-management of the disease.  However, due to the time limitations 
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reported by Chinese physicians and the difficulty to carry out a substantive consultation, it has 
been challenging to provide the ample amount of education addressing both general T1D care 
and nutrition-related T1D management. In response, a T1D clinic was recently developed at 
Peking University People’s Hospital in Beijing, China with aims to promote better nutrition 
education related to T1D care for patients with T1D in order for them to be able to independently 
maintain optimal glycemic control.  This project aimed to collect information to evaluate the 
nutrition education component of this pilot program in hopes to enable a more formally powered 
study in the future.   
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CHAPTER II: LITERATURE REVIEW  
T1D: Immune Pathogenesis and Genetic Etiology  
Genetically, researchers suggest certain mutations in specific genes that control for 
tolerance play a dominating effect over normal polygenic prevention of autoimmunity and thus 
contribute to the risk of T1D development.16 Particularly, “HLA” is a region of the human 
genome that includes genes encoding three classical HLA class II antigens (DQ, DR, DP) and 
three classical HLA class I antigens (A, B, C), and these products have been shown to increase 
susceptibility of T1D.16 The major genetic determinants of this disease are polymorphisms of the 
class II HLA genes encoding DQ and DR. 16 While the exact biological mechanism of HLA-
conferred T1D susceptibility remains unclear, current approaches for the prediction of T1D 
screening have involved genotyping HLA-DR and HLA-DQ loci combined with family history 
and screening for autoantibodies directed against islet-cell antigens.16 Thus, T1D may be defined 
by the presence of one or more specific autoimmune markers. These markers include islet cell 
autoantibodies and autoantibodies to glutamic acid decarboxylase (GAD), insulin, the tyrosine 
phosphatases (IA-2 and IA-2b, and ZnT8).17  
T1D: Environmental Triggers of Autoimmunity  
Some researchers also suggest that there are particular environmental triggers playing a 
role in altering immune function and  b-cell destruction that lead to development of T1D. 
Environmental triggers may then alter immune function and initiate β-cell destruction. 
Ecological correlation between incidence and various environmental, health, and economic 
indicators suggest that differences in environmental risk factors, such as nutrition and lifestyle  
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may be important in determining a country’s incidence rate.18 Environmental risk determinants 
for T1D may also be classified into three groups: viral infections, early infant diet (e.g. 
breastfeeding versus early introduction of cow milk’s components), and toxins.19 Further, The 
Environmental Determinants of Diabetes in the Young (TEDDY) study is a multicenter, 
multinational, epidemiological study that aimed to identify infectious agents, dietary factors, or 
other environmental exposures that are associated with increased risk of autoimmunity and 
T1D.20 This study also aimed to identify the factors influencing specific phenotypic 
manifestations such as early age of onset of T1D.20 Psychosocial stress was also explored as a 
potential trigger for T1D.20 In one finding of the study related to infant feeding and the effect of 
infant formulas on the risk of islet autoimmunity and T1D, researchers found that islet 
autoimmunity risk is not reduced, and may be increased by using hydrolyzed compared with 
non-hydrolyzed cow's milk-based infant formula as the first formula in infants at increased 
genetic risk for T1D.21 Thus, while the TEDDY study looked at many ecological evidence for 
triggers of T1D, it also suggested there are other environmental factors that may greatly be 
contributing to T1D development and progression. These factors, however, are still being 
explored and researchers are further investigating if there are specific genetic susceptibilities 
involved among different groups of individuals.20 
T1D: Micro- and Macrovascular Conditions  
Long-term diabetes-related complications may be characterized as both microvascular 
and macrovascular conditions, which account for most of the increased morbidity and mortality 
associated with the disease.22 Microvascular complications include retinopathy, nephropathy, and 
neuropathy. Diabetic nephropathy is the most common cause of renal failure in the developed 
world. Diabetic nephropathy progresses through a series of recognizable steps from subclinical 
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disease, to the earliest detectable phase of microalbuminuria (defined as a urinary albumin 
excretion rate 30-300 mg per day) to overt nephropathy or macroalbuminuria (>300 mg per day) 
with renal dysfunction and eventual end-stage renal disease. Macrovascular complications 
include cardiovascular, cerebrovascular, and peripheral vascular disease.1  
Microvascular Complications  
Diabetic retinopathy is the most common cause of acquired blindness in the western 
world, with a prevalence rate of proliferative retinopathy of about 20-25% in T1D. It also 
progresses through recognizable stages from early non-proliferative changes, previously called 
background retinopathy (micro aneurysms, exudates, and hemorrhages), which appear in almost 
all individuals with T1D by about 20 years duration, to pre-proliferative retinopathy and then to 
proliferative retinopathy and macular oedma.22 Screening for diabetic retinopathy should begin 5 
years after diagnosis in individuals of 15 years of age or older and be done yearly.22 The 
presence of diabetic retinopathy requires enhanced attention to glycemic, blood pressure, and 
lipid control, with laser therapy in sight-threatening diabetic retinopathy.   
Diabetic neuropathy refers to a complex group of conditions falling into two major 
categories: focal and generalized.22 Focal neuropathies include carpal tunnel syndrome, peroneal 
nerve and third cranial nerve palsies, and diabetic amyotrophy (proximal nerve conditions). The 
most common generalized neuropathy is sensorimotor polyneuropathy, which often first presents 
as a peripheral neuropathy alone, but often also affects the autonomic system with cardiac 
dysfunction, gastroparesis, and erectile dysfunction.22 Peripheral neuropathy, in conjunction with 
peripheral vascular disease, can lead to skin ulceration of the lower limbs, poor healing and 
gangrene, and amputation.22 Good foot care may greatly lower the risk of these outcomes. 
Screening for neuropathy should also occur approximately 5 years after T1D diagnosis with 
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appropriate methods: testing at the great toe with a ten-gauge monofilament to detect loss of 
sensitivity, and clinical assessment for the other manifestations. Attention to glycemic control 
represents the first step in management; if unsuccessful in controlling symptoms, referral to a 
specialist is recommended. Attention to preventive foot care is also essential.22 
Further, screening of individuals with T1D for microalbuminuria should be instituted 
early in the course of their disorder: the Canadian Diabetes Association suggests annual 
screening every year with a random urine albumin-creatinine ratio in post pubertal individuals 
with diabetes of duration 5 years or greater. Positive screening tests should be confirmed with 
further random albumin-creatinine ratios or timed urine collections for 2-3 months. Persistent 
positive results require introduction of reno-protective measures, including further intensification 
of glycemic control and control of hypertension or hyperlipidemia, or both, if present. First-line 
drugs of choice include angiotensin-converting enzyme inhibitors or angiotensin receptor-
blocking agents, both of which are highly effective in slowing progression of renal disease in this 
population.22 
Macrovascular Complications  
Cardiovascular disease (CVD) is a chronic complication of T1D. CVD prevalence rates 
in T1D vary substantially based on duration of T1D, age of cohort, sex, and race/ethnicity. 
Previous literature has specifically shown women with T1D are more likely to develop coronary 
heart disease (CHD), cerebrovascular disease(CBD), or peripheral artery disease (PAD) 
compared to those women without diabetes.23 Further, in the United Kingdom, CVD as defined 
as CHD, CBD and PAD were found to affect men and women with T1D equally at <40 years of 
age, but after age 40 were found to affect men more than women.24,25 Little is known about the 
relationship between race or ethnicity and CVD in T1D. The available data are primarily in 
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blacks. One study, The New Jersey 725 exclusively recruited a black cohort of patients with T1D 
from the New Jersey State Hospital database. This database suggested CHD, CBD, and PAD 
event rates are 8 times higher than what was reported in the white cohort from The Pittsburgh 
Epidemiology of Diabetes Complications (EDC) study.23,26 The DiaComp Study suggested 
similar rates of CVD risk factors across Asian, Hispanic, and non-Hispanic populations, however 
the population was too young for CVD events.23,27 These reports acknowledge that any 
differences related to race or ethnicity however could be genetic in which T1D acts differently 
based on race/ethnicity, or biological but mediated via other risk factors such as hypertension, or 
related to socioeconomic factors.23  In relation to age, the EDC study showed that the incidence 
of major coronary artery disease (CAD) events in adults aged 28-38 years with T1D was 0.98% 
per year and exceeded 3% per year after age 55 years, making it the leading cause of death in 
that population.23,28 By contrast, this incidence was found to be 0.1% in adults aged 35-44 years 
in individuals without diabetes.23,29 Based on other reports, the age-adjusted relative risk for 
CHD, CBD and PAD among T1D individuals was 10 times that of the general population.23,30-32 
Risk factors for cardiovascular disease in T1D include presence of diabetic nephropathy, 
autonomic neuropathy, dyslipidemia, and hypertension. Reduction of risk of vascular disease 
includes attention to healthy lifestyle (weight control and physical activity), smoking avoidance, 
with optimum glycemic, blood pressure (<130/80 mmHg in adults), and lipid control.22  
Diabetic Ketoacidosis (DKA) 
Diabetic ketoacidosis (DKA) is an acute metabolic T1D complication that is typically 
characterized by acidosis, ketosis and hyperglycemia.33 DKA is diagnosed by three main factors: 
elevated plasma glucose (>250 mg/dL), ketones in serum or urine, and acidosis (serum 
bicarbonate <18 mEq/L and/or pH<7.30). Acute symptoms of uncontrolled diabetes that may 
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lead to DKA include polyuria, polydipsia, polyphagia, weight loss, vomiting, abdominal pain 
and fatigue.33 Among all T1D-related deaths for patients 30 years or younger, 54-76% are 
attributed to DKA. 33 DKA may be treated with fluid and electrolyte therapy, insulin therapy, and 
treatment of other identified triggering causes (ie. continuous subcutaneous insulin infusion, 
pump failure, sepsis, pneumonia, acute pancreatitis, cerebrovascular accident, myocardial 
infarction, stroke, trauma, and medications that affect carbohydrate metabolism).33  
T1D: Emergence of Complications Early in Youth  
 Given the long-term increase in T1D worldwide, researchers sought to examine the early 
onset of various T1D-related complications (retinopathy, neuropathy, and nephropathy) and 
comorbidities (hypertension and arterial stiffness) among children and adolescents.34,35 One 
particular observational study published in 2017 investigated the prevalence of and risk factors 
for complications related to T1D among teenagers and young adults who had been diagnosed 
with diabetes during childhood and adolescence.35 The study collected data from 2002 to 2015 
from five US locations and included a total of 1746 participants with T1D (mean age 17.9 years 
± 4.1; 1327 non-Hispanic white; 867 female).35 Mean diabetes duration was 7.9 years and mean 
HbA1c was 9.2%.35 The main outcomes measured included diabetic kidney disease, retinopathy, 
peripheral neuropathy, cardiovascular autonomic neuropathy, arterial stiffness, and hypertension. 
Of this T1D sample, 5.8% had diabetic kidney disease, 5.6% had diabetic retinopathy, 8.5% had 
peripheral neuropathy, 14.4% had cardiovascular autonomic neuropathy, 11.6% had arterial 
stiffness, and 10.1% had hypertension.35 Overall, at an estimated age of 21 years and after 7.9 
years’ mean diabetes duration, approximately 1 in 3 teenagers and young adults with T1D had at 
least one complication or comorbidity, and these rates were suspected to increase.35 These results 
were from a US study of adolescents and young adults with youth-onset T1D whose data were 
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drawn from a population-based registry. Thus, this data coupled with previous work suggest that 
the participants in this study were reasonably representative of the general US population with 
onset of T1D in childhood or adolescence, although more evidence is needed to generalize on a 
global scale.35,36 Overall, these findings emphasize the need for early monitoring of these T1D 
patients for development of complications.   
T1D Management: Insulin Regimens and Bionic Pancreas   
Since patients with T1D are not able to produce insulin due to the autoimmune 
destruction of beta cells in the pancreas, these individuals need to inject insulin in order to 
breakdown glucose from meals and allow its uptake into other cells.37 The insulin regimen 
should ideally mimic physiologic insulin secretion and aim to restore normal metabolism.38  
Insulin cannot be taken as a pill because it would be broken down during digestion and therefore 
must be injected into the bloodstream.37 There are various types of insulin depending on how 
quickly they work, when they peak, and how long they last.37 Peak time is the time during which 
insulin is at its maximum strength in terms of lowering blood glucose.37 Rapid-acting insulin 
begins to work about 15 minutes after injection, peaks in about 1 hour and continues to work for 
2 to 4 hours.37 Regular, or short-acting insulin usually reaches the bloodstream within 30 minutes 
after injection, peaks anywhere from 2-3 hours after injection, and is effective for approximately 
3 to 6 hours.37 Intermediate-acting insulin generally reaches the bloodstream about 2 to 4 hours 
after injection, peaks 4 to 12 hours later, and is effective for about 12 to 18 hours.37 Long-acting 
insulin reaches the bloodstream several hours after injection and tends to lower glucose levels 
fairly evenly over a 24-hour period.37 Intermediate and long-acting insulins are often also called 
basal insulin, while short and rapid-acting insulin are often called bolus insulin. Basal-bolus 
insulin approach involve taking the longer-acting form of insulin to keep blood glucose levels 
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stable through periods of fasting and shorter-acting insulin to prevent extreme post-prandial rises 
in blood glucose.39  
The three basic regimens available for people who use a basal/bolus approach include a 
fixed dose regimen,  a sliding scale regimen, and matching insulin to carbohydrate.40  A fixed 
dose regimen involves using a set amount of insulin at each meal for which people are expected 
to a eat a consistent amount of carbohydrate meal-to-meal.40 Individuals with T1D who tend to 
eat the same type and quantity of food on a regular basis often find this type of dosing beneficial. 
However, this type of insulin dosing is more difficult for those who are used to eating a diet that 
varies more greatly with carbohydrate content.40 The sliding scale method is more precise than 
fixed dose insulin because it takes into account the fluctuation in blood glucose before and after 
meals.40 This method adjusts the dose of insulin based on blood glucose levels in which higher 
blood glucose allows for more insulin to be taken. However, this method requires the individual 
to check their blood glucose in order to know how much insulin to take.40 Similar to the fixed 
dose, the sliding scale approach assumes that consistent amount of carbohydrate is eaten at 
meals.40 This method works well for individuals who desire more control over their blood sugar 
and are willing to consistently monitor their blood glucose level and follow a structured meal 
plan. Finally, matching insulin to carbohydrate is a method that utilizes an insulin to 
carbohydrate ratio and a correction factor, along with a blood glucose target.40 The insulin to 
carbohydrate ratio indicates the amount of carbohydrates (in grams) one unit of insulin will 
provide coverage for. The correction factor indicates the glucose lowering power for one unit of 
insulin.40 This method is more flexible than fixed dosing or sliding scale because it allows for 
differences both in glucose levels and carbohydrate intake, however it requires adequate nutrition 
education and arithmetic skills to count carbohydrates or servings.40  
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Insulin may be delivered through three main methods: insulin injections, insulin pumps, 
and a bionic pancreas.41,42 Injections may be more beneficial for some individuals because they 
require less education and training than pump therapy, and they are often cheaper in price.41 
However, injections may make it more difficult to control blood glucose levels if individuals 
need to inject different types of insulin.41 Insulin pump therapy delivers insulin continuously 
throughout the day causing fewer sudden highs and lows in blood glucose levels.41 Another 
reason insulin pump therapy is often preferred is the fact that less needle sticks are required. 
Pump therapy may require only one injection (hook up) every three days versus 15-18 injections 
in a three-day period with injection therapy.41   
While insulin regimens are believed to affect T1D-related metabolic outcomes, this 
relationship is complex.43  In previous observational studies in children, insulin pump use has 
been associated with lower HbA1c, fewer episodes of severe hypoglycemia and seizures, as well 
as improved quality of life.43-47 In a short-term randomized control trial of insulin pump therapy 
versus multiple daily injection (MDI) therapy, insulin pump was associated with a sharp 
reduction in HbA1c levels, while those using MDI showed no significant change in HbA1c.48 
However, an alternate study found HbA1c levels and frequency of acute complications were 
similar between insulin pump users and patients on MDI therapy, although the cost of therapy 
was 4 times higher for insulin pump users.48 Researchers of the SEARCH for Diabetes in Youth 
study, aimed to further explore the insulin regimens used to treat T1D in youth in the United 
States and to describe the associations between insulin regimen and clinical outcomes, 
particularly glycemic control.43 Among a total of 2743 subjects who participated in the study, 
researchers found associations between sociodemographic characteristics and insulin regimen. 
Specifically, they found insulin pump therapy was more frequently used by older youth, females, 
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non-Hispanic whites, and families with higher income and education.43 However, they also 
found insulin pump use was associated with lowest HbA1c levels in all age groups.43 Similar 
trends between insulin pump use and HbA1c levels were seen in adults. The most recent update 
of the T1D Exchange clinic registry showed among adults ages 18-25 years (n=2832), 55% of 
participants in this age group used an insulin pump and had a mean HbA1c of 8.4% ± 1.6 while 
the remaining 45% were injection users and had a higher mean HbA1c of 9.1% ± 2.1.49 Among 
adults ages 26-49 years old (n=2565), 63% used an insulin pump and the remaining 35% were 
injection users, with HbA1c levels of 7.6% ± 1.2 and 7.8% ± 1.5, respectively.49 Finally, among 
those ages 50 years or older (n=2096), 60% were insulin pump users while the remaining 40% 
were injection users, with HbA1c levels of  7.5% ± 1.0 and 7.7% ± 1.2, respectively.49  Based on 
this registry, diabetic ketoacidosis (DKA) was also found to occur less frequently in insulin 
pump users than injection users among both youth and adult populations in the US. 50,51    
Finally, a bi-hormonal bionic pancreas is a third method of T1D insulin treatment that 
uses continuous glucose monitoring and mathematical algorithms to automatically administer 
both insulin and glucagon.42 Mathematical algorithms and user interface are often ran as an app 
on and iPhone or other electronic device.42 One recent study published in 2017 aimed to assess 
whether bi-hormonal bionic pancreas initialized only with body mass can reduce mean 
glycaemia and hypoglycemia in adults with T1D who were living at home and participating in 
their normal daily routines without restrictions on diet or physical activity.42 The study randomly 
assigned 43 participants between May 2014 to July 2015 to bionic pancreas (intervention period) 
or their own insulin pump (and continuous glucose monitor, CGM, if typically used) according 
to their usual practice (comparator period).42 The bionic pancreas adapted dosing insulin to each 
participant’s needs automatically.42 When CGM data were not available, the bionic pancreas 
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invoked automatic basal insulin dosing on the basis of mean basal dosing delivered at 
corresponding times on previous days.42 Automatic correction doses of insulin or glucagon were 
delivered in response to manually entered blood glucose measurements that the system requested 
once per hour when CGM data were unavailable.42 No insulin was given other than by the bionic 
pancreas.42 Results of the study suggested that relative to conventional and sensor-augmented 
insulin pump therapy, the bi-hormonal bionic pancreas was able to achieve superior glycemic 
regulation without the need for carbohydrate counting.42 However, larger and longer studies are 
needed to establish the long-term benefits and risks of automated glycemic management with a 
bi-hormonal bionic pancreas.42 Meanwhile, “artificial pancreas” systems have evolved to more 
fully integrated closed-loop systems that calculate all continuous insulin delivery with and 
without meal bolus delivery.52 The MiniMed 670G System from Medtronic is the first 
commercial hybrid closed-loop (HCL) system available globally.52 The system functions in two 
modes: open-loop (OL) “Manual Mode” (insulin pump with or without sensor) and HCL “Auto 
Mode,” in which the system algorithmically calculates background “auto-basal” insulin delivery 
based on CGM glucose values, with predefined insulin delivery limits adapted daily.52 Basal 
rates, carbohydrate to insulin ratios, insulin sensitivity factors, and glucose targets are modifiable 
with both modes.52 A recent study published in 2018 aimed to compare insulin delivery patterns 
and time-in-range metrics in HCL and OL modes, as well as to examine system alerts, usage 
profiles, and operational parameters in order to provide suggestions for optimal clinical use. The 
study recruited 31 adolescents and young adults (14-26 years old) with T1D at three clinical 
sites.52 Participants had a 2-week run in period in OL followed by a 3-month in-home study 
phase with HCL function enabled.52 Researchers found that in transitioning young patients to the 
670G system, providers should anticipate immediate carbohydrate to insulin ratio adjustments 
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while also assessing active insulin time.52 Overall, unique 670G system functionality requires 
ongoing clinical guidance and education from providers.52  
T1D Management: Monitoring Blood Glucose   
While insulin was initially thought to represent a cure for T1D after its first discovery in 
1921, acute morbidity and mortality as well as a series of chronic complications still occur.19 The 
Diabetes Control and Complications Trial (DCCT) research group showed the importance of 
strict metabolic control for the delay and prevention of chronic complications.19 Devices that 
promote continuous glucose monitoring (CGM) and routine determination of HbA1c are 
important for individuals to have euglycemia without risk of severe hypoglycaemia.19 CGM 
allows users to be informed of glucose measurements and trends as often as every 5 minutes, as 
well as alerts when glucose levels are too low or too high.53 A DIAMOND randomized clinical 
trial found that among adults with T1D who used multiple daily insulin injections, those who 
used CGM as opposed to blood glucose meter testing (performed several times a day) had a 
greater decrease in HbA1C level during a course of 24 weeks.53 This same prospective 
randomized trial also recently assessed the influence of 24 weeks of CGM use on quality of life 
(QOL) in adults with T1D who use multiple daily insulin injections.54 Major findings showed 
CGM contributed to significant improvement in diabetes-specific QOL including diabetes 
distress and hypoglycemic confidence, but not with QOL measures non-specific to diabetes such 
as well-being and health status.54 Nonetheless, this DIAMOND study was the first study to 
demonstrate the introduction of appropriate diabetes technology that can positively influence this 
critical diabetes QOL dimension.54 
Self-monitoring blood glucose (SMBG) is another method of monitoring glycemic status. 
Optimal use of SMBG requires regular checking of capillary glucose using a glucometer, 
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appropriate and timely entry in a logbook, and proper review and interpretation of the data both 
by the patient and caregiver of pediatric patients.55 A recent 2017 study assessed the accuracy of 
recording SMBG information in logbooks and its impact on long-term glycemic control among 
n=101 children with T1D from a tertiary care center in eastern India.55 Main findings included 
children with accurate logs of SMBG readings were significantly more likely to have better 
glycemic control (lower HbA1c) on long-term follow up than those who had inaccurate blood 
glucose logs.55 Further, another recent study in Kyoto, Japan assessed the relationship between 
the frequency of SMBG and glycemic control among T1D adults on continuous subcutaneous 
insulin infusion (CSII) or on multiple daily injections (MDI).56 Results showed that the odds 
ratio of achieving a target HbA1c level of <8% was significantly higher in subjects with SMBG 
frequencies of ³ 3.5 times/day compared with those with SMBG frequencies of <3.5 times/day in 
the CSII group, but not in the MDI group.56 Additionally, a significant correlation between 
SMBG frequency and the HbA1c level was detected in the CSII group, but not in the MDI 
group. Final conclusions from this study suggested a SMBG frequency of <3.5 times/day was a 
risk factor for poor glycemic control in T1D patients on CSII.56 Likewise, a similar study 
assessing frequency of SMBG and its correlation with HbA1c and acute complications in 
n=26723 children and adolescents aged 0-18 years with T1D from 233 centers in Germany and 
Austria, also found higher frequency of SMBG among those on a CSII regimen compared to 
MID. Further SMBG frequency was significantly associated with better metabolic control with a 
drop of HbA1c of 0.20% for one additional SMBG per day. However, increasing SMBG 
frequency above 5/day did not result in further improvement of metabolic control. Further only 
among adolescents aged >12 years was HbA1c improved distinctly with two or more blood 
glucose measurements.57  
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T1D Management: General Dietary Patterns 
The ADA published nutrition recommendations emphasizing individualization of dietary 
advice with a focus on the effects of nutrition therapy on metabolic control.22 The most recent 
ADA recommendations reiterate that there is no “one-size-fits-all” diet for individuals with 
diabetes and that food choices should only be limited when supported by scientific evidence.58 In 
the United States, one study reported that adults with T1D had a higher mean percentage of 
energy from fat and protein and a lower mean percentage of energy from carbohydrates 
compared to controls.58 A similarly higher mean percentage of energy from fat compared to 
controls has also been observed in several small samples of youth T1D in the U.S. and in 
Europe.15,58 Managing dietary intake with insulin treatment is an integral part of T1D care. For 
more information on insulin dosing in relation to carbohydrate counting and overall dietary 
intake refer to “T1D Management: Insulin Regimens.” 
T1D Management: Islet Transplantations  
Other forms of treatment include islet transplantation. The National Institutes of Health 
established the Clinical Islet Transplantation (CIT) Consortium to evaluate more rigorously the 
risks and benefits associated with islet transplantation in T1D individuals who demonstrate 
impaired awareness of hypoglycemia (IAH) and severe hypoglycemic events (SHEs).59 This was 
a multicenter, single-arm phase 3 study of the investigational product purified human pancreatic 
islets (PHPI) conducted at eight centers in North America. There was n=48 adults with T1D 
duration of >5 years who each received immunosuppression and one or more transplants of 
PHPI.59 Final conclusions of the study found that transplanted PHPI provided glycemic control, 
restoration of hypoglycemia awareness, and protection from SHEs in subjects with intractable 
IAH and SHEs.59 Islet transplantation was suggested to be recommended for patients with T1D 
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and IAH in whom other less invasive current treatments have been ineffective in preventing 
SHEs.59  
T1D Management: Gene Therapy 
Gene therapy might be promising for promotion of euglycemia. Two recent studies, one 
using gut K cells and the other involving liver cells, showed that the insulin gene delivery could 
be both glucose responsive and establish euglycemia. 19 Further, drugs for prevention of specific 
complications include ACE inhibitors for nephropathy, rigorous control of lipids with new 
generation statins, and protein kinase C inhibitors.19  
T1D in China: Incidence and Temporal Trends in China  
The overall incidence of T1D in China is very low in comparison to that of other 
countries. An early DIAMOND study 
published in 2000 investigated the 
incidence of T1D (per 100 000 per 
year) from 1990 to 1994 among 
children £ 14 years of age from 100 
centers in 50 countries.60 A total of 
19,164 cases were diagnosed in study 
populations totaling 75.1 million 
children. The study’s results showed incidence rates to be highest in Europe and populations of 
European origin (eg. USA, Canada, Australia, and New Zealand), while China had the lowest 
incidence of 0.1.60 However, since this study, the incidence in China has been rising. The most 
recent China registry published in 2017 investigated T1D incidence in China from 2010 to 2013 
across all age groups (n=849).61 Incidence rates were 1.93, 1.28, and 0.69 per 100 000 person-
Figure 1. Map of China  
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years for age groups 0-14, 15-29, and ³30 years, respectively.61  The estimated incidence of T1D 
for all ages in China was 1.01. 61 
Although the incidence rates in China are relatively low compared to the United States 
and Northern regions of Europe, China has the largest number of people with T1D in the 
Western Pacific Region.62 Within China, the highest incidence was found in the region of Wuhan 
(4.6 per 100,000 per year) and lowest in Zunyi (0.1 per 100,000 per year).63 See Figure 1 for a 
Map of China. 
T1D in China: Self-Management   
Currently, data on T1D care outside the United States and Europe are limited. Between 
2001 to 2002, the International Diabetes Federation conducted a cross-sectional study on 
glycemic control and diabetes self-management, and found that children and adolescents with 
T1D in China had the lowest mean daily insulin dose and the lowest frequency of SMBG among 
Western Pacific countries.9,64 This low SMBG frequency poses a significant barrier for 
physicians in China as well, who cannot advise patients appropriately with respect to diet 
because patients do not bring SMBG results to their outpatient visits.9 In a recent study 
performed in Guangzhou city, a relatively developed district in China (see Figure 1), an 
information-motivation-behavioral skills (IMB) model of health behavior was used among T1D 
patients to investigate behavioral factors affecting the practice of SMBG.65The study found 
major SMBG information deficits including 50.9% of participants not understanding the 
meaning of high blood sugar before exercises and 47.3% not understanding the kind of food that 
should be taken when blood sugar was low.65 In addition, one-fifth of participants did not 
understand the different meanings of HbA1c and SMBG results and the necessity to practice 
both.65 The lack of diabetes educators in China and the common requirement of inpatient 
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admission to receive diabetes education are major barriers to proper T1D patient self-
management.9 Other motivation obstacles included 85.5% of participants viewing the cost of 
testing to be “too expensive” or adhering to doctor’s recommendations to be “painful” (72.7%).65 
Although insulin is covered in part by most health insurance policies, insulin injection tools, 
blood glucose testing strips and blood glucose meters are not covered by insurance.9 Behavioral 
limitations involved 63.6% of participants feeling it was difficult to discuss diabetes with 
workmates and friends, and 58.2% finding it challenging to buy test strips conveniently.12 These 
findings suggest possible reasons for study’s low compliance rate (36.4%) of the ADA 
recommendation to test blood glucose three times daily.65 These results based on the IMB 
framework are important findings that may provide potential-focused education targets for 
diabetes health care providers.65 
T1D in China: Nutrition Therapy  
In 2014, the first study to assess the integration of diabetes nutrition therapy, self-
management practices, and dietary intake among T1D patients in a developing country was 
conducted in China.9 Researchers of this study found that there was a low frequency of diabetes 
nutrition therapy approaches, such as carbohydrate counting.9 Instead, data from the study 
suggest majority of diabetes nutrition therapy consists of matching fixed insulin doses to a diet 
that is rigid with respect to amount and timing.9 This method of nutrition therapy makes it 
difficult for some T1D patients to adhere to due to the desire to consume a more flexible and 
diverse diet.    
Further, the study showed that fewer than half of participants had ‘ever’ met with a 
dietitian, and it suggested that dietitians are only used in high-risk situations.9 Only 18% had 
attended an education session in the preceding 12 months, which may explain why only 12% of 
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participants sometimes used carbohydrate counting and 32% sometimes followed an eating plan 
given to them by their healthcare provider.9 This is notably in contrast to youth with T1D in the 
US, where 97% have been taught carbohydrate counting and 86% report using this method 
‘often.’ 9 As a result, lack of nutrition education from this study indicated an insufficient 
foundation among T1D  patients to implement changes to their diet.9 From the study, 74% of 
participants desired to learn more about how food interacts with their diabetes care.9 Therefore, 
there is a strong need in China for more integration of nutrition education by trained clinical 
dietitians during routine patient care in order to help patients in China gain a better 
understanding of nutrition and its influence on glycemic control.  
T1D in China: Dietary Patterns  
A recent study that compared the dietary intakes of individuals with T1D to that of 
individuals without T1D, found most T1D participants followed a fixed insulin regimen matched 
with a rigid meal plan, with respect to timing and amount of food.66 Overall, compared to 
individuals without T1D, individuals with T1D in China had a lower mean percentage of energy 
from carbohydrates and a higher mean percentage of energy from fat and protein.66 Additionally, 
participants who were on fixed insulin regimens had higher intake of wheat products and 
consumed less fruit, but more high-fat cakes and dairy compared to those without T1D.66 Higher 
consumption of high-fat cakes was suggested to be a result of sugar-free cakes tending to be 
higher in fat, and patients may have been instructed to focus on low-sugar, low-carbohydrate 
foods, rather than fully comprehend the totality of the nutritional information.66 However, in a 
later study it was found that consumption of high-fat cakes was inversely associated with HbA1c 
levels in T1D participants and consumers of wheat products had significantly lower LDL 
cholesterol compared to non-consumers.67  Individuals with T1D on fixed insulin regimen also 
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restricted fruit intake, which suggests another result of focusing on low-sugar or low-
carbohydrate intake without considering the aspects of an overall healthy, balanced diet.66 Lack 
of physician-patient time and dietitian involvement in T1D care in China may be potential 
barriers to comprehensive educational nutrition counseling.66 On the other hand, participants on 
basal-bolus regimens were less likely to consume fried foods and more likely to consume 
fish/shellfish.66 This group also consumed more protein than those with T1D on a fixed insulin 
regimen.66 Thus, given the lower amounts of fried foods consumed, this group of participants 
with T1D had a generally healthier diet than those with T1D on a fixed insulin regimen. It was 
therefore suggested that T1D patients on a basal-bolus insulin regimen are likely more motivated 
to adhere to self-management relating to dietary intake and nutrition.66In both insulin regimen 
groups, participants with T1D had an overall higher intake of vegetables, fungi/seaweed, and 
low-fat cakes compared to individuals without T1D. Fungi is often used as an example for a 
“sugar free” food during diabetes education courses and the increased intake of low-fat cakes, 
such as biscuits/crackers is often consumed to treat hypoglycemia in China. 66  The study also 
found that participants with T1D overall consumed less dietary fiber than non-T1D participants, 
and further found that mean fiber intakes were below the recommended level of 14 g/1000 
kcal.66 Thus, given that fiber is associated with reduced all-cause mortality and reduced 
cardiovascular disease risk among individuals with diabetes, there is a need to identify strategies 
to help promote an increase in dietary fiber intake in future research.66  
T1D in China: Elevated HbA1C and Dietary Patterns 
The recommended target for HbA1c among T1D patients in China is less than 7.5% for 
children and adolescents and less than 7% for adults.68 Testing is recommended four to six times 
per year in younger children and three to four times per year in older children and adults.68 Past 
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literature has demonstrated, however, that majority of patients with T1D in China struggle with 
HbA1c levels well above the target range. In the 3C study, researchers used a cross-sectional 
design to explore the clinical practices and outcomes of people with T1D in two cities in China: 
Beijing and Shantou (n=849).68 Participants were recruited from hospital records, inpatient 
wards, and outpatient clinics. Data was collected via face-to-face interviews with patients and 
health professionals, the Summary of Diabetes Self-Care Activities, medical records, and venous 
blood samples.68 The mean HbA1C in Beijing and Shantou across all age groups was 8.3% ± 1.9 
and 9.9% ± 2.7, respectively, with the overall mean of both cities being 8.9% ± 2.4.68 In Beijing, 
HbA1c was highest among adolescents ages 13-19 years old with an HbA1c of  8.6% ± 2.1.68 In 
Shantou HbA1c was highest among children <13 years old with HbA1c of 10.7% ± 2.8.68 
Overall mean HbA1c of both cities was highest among adolescents ages 13-19 years which 
showed HbA1c of 9.4% ± 2.5.68 Across all age groups (p = 0.006), HbA1c levels were 
significantly higher in Shantou than in Beijing (p = 0.002).68 In Beijing, children were most 
likely to receive an HbA1c test three times or more per year, in Shantou, adults were more likely. 
More than one fifth of participants in Beijing however did not have an HbA1c test in the 
previous year, and in Shantou it was almost two fifths. Among those who were tested, once per 
year was the most common testing frequency.68 
Past literature has suggested associations between specific dietary patterns in China and 
decreased levels of HbA1C. In a meta-analysis of prospective cohort studies, a one-percentage 
point increase in HbA1c was associated with an increase in CVD risk of 18%, thus this finding is 
clinically meaningful.69 The previous study mentioned in “T1D in China: Dietary Patterns” 
found an inverse association between “high-fat cakes” and HbA1C among Chinese adults with 
T1D.67 Participants in this specific study’s sample had an HbA1c of 7.9% . Researchers of this 
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study discussed the reasoning for this association could be explained by the fact that majority of 
T1D patients were told “to limit their sweet intake,” and as result many patients chose sugarless 
cakes that are higher in fat over low fat cakes that are higher in sugar.67 This same study also 
suggested that a dietary pattern characterized by high bean and bean product intakes (typically 
soy-based products such as tofu) among Chinese adults was associated with higher HbA1c, 
although more research is certainly needed to understand the effects of bean and bean product 
intake on health in this population.67  
These findings provide support for the need of educational and behavioral strategies to 
prevent health complications, such as CVD, among patients with T1D in China.  
T1D in China: Stigma  
A major barrier to improving care for individuals with type 1 diabetes is the stigma that 
exists towards the disease, which has led to stereotyping, labeling, and devaluing of individuals 
with T1D.70 One of the reasons underlying this stigma may be the extremely low incidence of the 
disease.13,70 Its rarity establishes those with T1D to be portrayed as unusual, or ‘monsters’ by 
society.70 The stigma surrounding T1D in China has led to difficulties for individuals to establish 
friendships and relationships with others.70 Further, there is a government regulation that states 
individuals with ‘severe endocrine and metabolic diseases’ should not be admitted to universities 
or junior colleges, or employed by the government. The resulting structural discrimination has 
caused individuals with T1D to hide their diabetes in order to gain acceptance into colleges or 
jobs.70 This stigma has also prevented many individuals to seek proper treatment, or sufficiently 
adhere to treatment plans in fear of having to inject their insulin dose in a public setting. 70 
Health care providers should therefore take a holistic, rather than solely biomedical approach, 
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when advising patients with T1D, in order to account for how stigma may represent significant 
barriers to optimal T1D self-management.
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CHAPTER III: PRELIMINARY STUDY 
The current study is an expansion of a preliminary study that aimed to investigate two 
main research questions that focused on 1.) whether nutrition knowledge influenced adherence to 
recommended meal plans and carbohydrate counting and 2.) the common perceived barriers that 
may influence adherence to meal plans and carbohydrate counting among type-1 diabetes 
patients in Beijing, China. This preliminary study utilized quantitative methods through an online 
survey to assess nutrition knowledge among T1D patients in two main topics: healthy foods and 
reading and understanding a nutrition label. The survey also included questions on use of current 
dietary treatment plan associated with T1D management, as well as patients’ perceived barriers 
when managing their disease. The study ultimately aimed to assess the association between 1.) 
nutrition knowledge and adherence to meal planning and carbohydrate counting (CC) and 2.) 
total number of barriers perceived and adherence to meal planning and carbohydrate counting. 
Furthermore, the study utilized quantitative methods via another online survey targeted towards 
health care providers at the Peking University People’s Hospital in Beijing, China in order to 
assess providers’ perspectives on their T1D patients’ most common barriers to managing their 
diet with respect to their insulin regimen and overall T1D care.  
This preliminary study recruited 82 participants with T1D and 11 health care providers 
that included 9 endocrinologists, 1 nurse, and 1 dietitian. Major findings showed an overall lack 
of nutrition knowledge among T1D patients with participants scoring very low in both categories 
of nutrition knowledge assessment (Table 2).  However, of the two categories, participants 
scored higher on the ‘Nutrition Labels’ questions than the ‘Healthy Foods’ questions.
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Other findings demonstrated only a significant association between ‘Healthy Foods’ 
scores and CC adherence which showed those who scored less than 50% on the ‘Healthy Foods’ 
questions had a ‘High’ adherence to CC (Table 3).  No other significant associations were found 
between nutrition knowledge and meal plan or CC adherence.   
Table 3. Preliminary Study: Nutrition Knowledge Score vs. Adherence to Meal Plans and CC  
 
 
 
 
 
 
 
 
 
When investigating patients’ perceived barriers and adherence, the statement “I want to 
eat more foods than what my doctor recommends” was associated with a lower meal plan 
adherence (p=0.02); the statement “I do not read food labels because I do not think it is 
important” was associated with a lower CC adherence (p=0.01);  and the statement “I want to 
read the food labels but do not because the food labels are hard to understand” was associated 
with lower adherence to CC (p=0.02).  There was no significant association between total 
number of barrier perceived by patients and adherence to meal plans and CC. On the provider 
 
 
 
 
 
Table 2. Preliminary Study: Nutrition Knowledge Mean Scores (n=82)  
 
Nutrition Knowledge Questions Mean % ± SD 
Healthy Foods  60.9 ± 17.1 
Nutrition Labels 70.6 ± 20.2 
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side, about 82% of providers perceived many of their patients’ finding the meal plan they were 
given to be “too strict” and 73% believed the meal plans were “not practical” and included many 
foods that the patient did not normally consume. Less than 20% of providers believed cost or 
access to recommended healthy foods was a major barrier for T1D patients.  
The results of this study suggested a serious lack of nutrition knowledge and dietary 
management among T1D patients, including general knowledge on healthy diets, as well as 
knowledge on reading and understanding nutrition food labels.  This lack of knowledge and 
dietary management is likely contributing to an overall poor management of T1D among these 
patients. Further, both patients and providers report the challenge of adhering to a strict meal 
plan which suggests an urgent need for a more flexible insulin regimen for T1D patients in order 
to accommodate a more flexible diet. This will require specific nutrition education pertaining to 
1.) basics of a healthy diet, 2.) reading and understanding a nutrition food label, and 3.) 
carbohydrate counting.  
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CHAPTER IV: RESEARCH QUESTION & STUDY AIMS 
The main results of the preliminary study summarized in Chapter III support previous 
literature that demonstrated a lack of nutrition knowledge related to T1D management in China 
and it further emphasizes the serious need for more nutrition education among T1D patients. In 
response to this urgent need, health care providers at the Peking University People’s Hospital in 
Beijing, China are determined to provide better education and resources for T1D patients in 
order to allow them to learn more about their diabetes and the best way to maintain their 
glycemic control with their diet and lifestyle.   
As a result, a T1D clinic was initiated in June 2017 at the Peking University People’s 
Hospital in Beijing, China. The clinic’s goal is to establish a more patient-focused healthcare 
setting, in order to promote nutrition and diabetes education that is more tailored to each 
patient’s specific dietary lifestyle. For this study, the development of this new T1D clinic and its 
educational approach allowed us to investigate the following research question:   
 
Does implementation of a brief nutrition educational intervention improve overall nutrition 
knowledge and type-1 diabetes (T1D) management among T1D patients in Beijing, China?
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To address this question, researchers evaluated this pilot program in order to estimate its 
potential effect and enable a more formally powered study in the future.  This research study 
specifically investigated two main aims as described below:  
AIM 1: Use quantitative methods to assess the implementation of a brief nutrition educational 
intervention on three measures of nutrition knowledge: (a.) basics of a healthy diet (b.) reading 
and understanding nutrition food labels, and (c.) knowledge and use of carbohydrate counting, 
among T1D patients in Beijing, China.  
Data collection occurred through administration of paper and electronic surveys. Surveys were 
conducted pre-post the nutrition consultation at the T1D clinic.  
v Hypothesis: Implementation of a brief nutrition educational intervention will overall 
demonstrate improvement in all three measures of nutrition knowledge among the type-1 
diabetes patients receiving care from the Peking University People’s Hospital T1D clinic.   
AIM 2: Use quantitative and qualitative methods to inform next steps for the nutrition 
educational type-1 diabetes management program at the Peking University People’s Hospital in 
Beijing, China.  
Exploratory analyses looked at associations between changes in nutrition knowledge score and 
participants’ perception of the nutrition booklet. Descriptive analyses looked at associations 
between participants’ baseline HbA1c and nutrition knowledge as well as between baseline 
HbA1c and past diabetes and carbohydrate counting education. Lab measurements were 
obtained at baseline through medical record review performed by clinic physicians.  
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CHAPTER V: MANUSCRIPT 
Overview  
 There is a serious lack of nutrition and diabetes education among type-1 diabetes (T1D) 
patients in China which has made it difficult for many patients to manage their dietary intake 
with their insulin treatment. As a result, patients with T1D in China face challenges with 
maintaining optimal glycemic control and many demonstrate hemoglobin A1C (HbA1c) levels 
highly exceeding the target value of 7.5% in all age groups. In response to this lack of education, 
a nutrition education intervention was recently developed at a T1D clinic in the Peking 
University People’s Hospital in Beijing, China. This study is a program evaluation of this pilot 
nutrition education intervention. The study specifically aimed to assess three measures of 
nutrition knowledge (basics of healthy diet, food labels, and carbohydrate counting) pre- and 
post-intervention using two nutrition education surveys (NKES 1 and NKES 2).  The study also 
aimed to use quantitative and qualitative methods to gain patient feedback in order to inform 
future steps for the intervention. Descriptively, there was an overall improving trend in all three 
measures of nutrition knowledge post-intervention, however there was only statistical 
significance in the difference in scores for “Healthy Diet” and “Carbohydrate Counting” 
questions.  The study also found great variation in baseline nutrition knowledge among patients, 
which suggests a need for modifications to the intervention to better match educational resources 
to patient’s baseline knowledge. Future modifications should also include collection of HbA1c 
post-intervention to assess physiological applicability of the intervention. 
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Introduction  
The incidence of type 1 diabetes (T1D) in China is one of the lowest worldwide.13 Based 
on an early DIAMOND study that investigated the global incidence of T1D among youth, China 
was found to have a T1D incidence of 0.1 per 100,000 population which was especially low 
compared to incidence rates in Europe and other populations of European origin, such as the 
United States, Canada, and Australia where incidence rates ranged from 14.5 to 40.1.13 However, 
based on the most recent China registry, overall estimated T1D incidence in China has risen.61 
Although the overall incidence rate in China continues to be lower in comparison to that of the 
United States and Northern regions of Europe, China has the largest number of people with T1D 
among the Western Pacific Region.62   
 As incidence of T1D is continuing to rise, researchers are increasingly becoming more 
attentive to how the disease is being managed among patients. Previous literature has suggested 
that T1D management in China is overall very poor.68 Studies performed in numerous different 
regions in China have found mean HbA1c levels of T1D patients across all age groups to be 
higher than the target HbA1c of less than 7.0% among adults and less than 7.5% among 
children.67,68 Researchers have suggested that elevated HbA1c among T1D patients in China may 
be associated with reports of low frequency of HbA1c testing and self-monitoring of blood 
glucose (SMBG).9,64,68 Further, many patients admit to difficulty understanding how to 
effectively integrate diabetes nutrition therapy with their insulin treatment making it more 
challenging to maintain optimal glycemic control.9 
 Additionally, majority of diabetes nutrition therapy in China consists of using fixed 
insulin dose regimens to a diet that is more structured with respect to amount and timing.9  This 
method of nutrition therapy makes it more difficult for many T1D patients to adhere to their 
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given meal plan due to a desire to consume a more flexible and diverse diet. Alternate 
approaches to diabetes nutrition therapy such as matching insulin to various amounts of 
carbohydrate consumed requires more education and practice with carbohydrate counting, which 
many T1D patients in China currently lack.9 Further, the lack of diabetes educators and T1D 
nutrition educational resources, as well as the requirement of inpatient admission to receive 
diabetes education has been reported to be major barriers to proper T1D self-management among 
patients.9 Therefore, there is a serious need of nutrition educational and behavioral strategies to 
prevent health complications among patients with T1D in China. Improving nutrition knowledge 
related to T1D management may ultimately contribute to reduced levels of HbA1c and overall 
improve health outcomes, including cardiovascular disease risk, among T1D patients.67  
 In response to the urgent need of nutrition and diabetes education among T1D patients, a 
T1D clinic was initiated in June 2017 at the Peking University People’s Hospital in Beijing, 
China. The goal of this clinic is to establish a more patient-focused healthcare setting in order to 
promote nutrition and diabetes education that is more tailored to each patient’s specific dietary 
lifestyle. The nutrition education intervention at the T1D clinic is currently part of standard 
clinical care at the Peking University People’s Hospital in Beijing, China. The intervention 
consists of two main components: nutrition education and motivational interviewing 
(MI)/problem solving skills training. This study evaluated the nutrition education component of 
the intervention utilizing two nutrition knowledge and education surveys (NKES 1 and NKES 2) 
that were administered pre-and post-intervention at specific time points in accordance with each 
patient’s baseline and follow-up visits. It is important to note that this clinic’s intervention is 
ongoing and patients have continued to receive nutrition education and MI/problem solving skills 
training since the end of this study’s program evaluation.  
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Methods  
The Intervention  
The T1D clinic consists of a nutrition educational intervention that is currently part of 
standard clinical care at the Peking University People’s Hospital in Beijing, China. This 
intervention consists of two main components: nutrition education and motivational 
interviewing/problem solving skills training.  
For the nutrition education component, researchers of the study from UNC-CH 
collaborated with the endocrinologist and dietitian from the Peking University People’s Hospital 
in Beijing, China to develop a culturally appropriate nutrition booklet for T1D patients. This 
booklet was created to be used by the providers at the Peking University People’s Hospital T1D 
clinic as part of the clinic’s standard protocol of care. The booklet consists of information on 
balanced and healthy diets with colorful illustrations of a Chinese MyPlate and Food Pagoda to 
help patients understand the different food groups. The booklet also contained information on 
how to appropriately read and interpret Chinese food labels using a specific food label as an 
example. The third main component of the booklet contained important information on 
carbohydrate counting and insulin management, including content on insulin to carbohydrate 
ratios and insulin correction factors. A thorough food list with nutrition information, such as 
estimated grams of carbohydrates per serving size, of commonly eaten foods in Beijing, was 
provided in the back of the booklet for patients to refer to when preparing their own meals at 
home. Further, illustrations of different size hands and palms for estimating food amounts were 
used as alternate methods to weighing.  
The clinic’s intervention program consists of at least three main clinic visits. The first 
visit allows for patients to raise their main issues on managing their dietary intake with their 
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T1D. At this visit, patients are introduced to the nutrition booklet and mainly educated on basics 
of a healthy diet and food labels. At this first visit, patients receive an introduction to 
carbohydrate counting, however this concept is not explained in detail until the following visit. 
At the first visit, patients ultimately develop a shared agenda with the provider and begin to set 
realistic nutrition-related goals through problem-solving training and motivational interviewing. 
Patients are encouraged to review the booklet at home after this first visit and to practice the 
skills taught in the booklet and by the provider from the intervention.  
One month later, patients are expected to follow-up for their second visit in the clinic. At 
the second visit, patients address dietary challenges and receive more detailed education on 
carbohydrate counting and insulin to carbohydrate ratios. At this second visit, providers assess 
the patient’s progress and determine if the patient is ready to set new nutrition-specific goals. 
Following another month, patients return for their third visit where they continue to 
review their goals and progress, as well as identify new barriers related to their dietary intake and 
T1D management. At all visits patients are encouraged to ask questions to the providers in order 
to gain a more thorough understanding of the concepts being taught.  
Ultimately, the study aimed to evaluate this pilot program intervention in order to 
estimate its potential effect and enable a more formally powered study in the future. Specifically, 
this study used quantitative methods to assess the implementation of a brief nutrition educational 
intervention at the clinic using three main measures of nutrition knowledge: 1.) basics of a 
healthy diet, 2.) reading and understanding nutrition food labels, and 3.) knowledge and use of 
carbohydrate counting. Researchers hypothesized that implementation of this intervention will 
overall demonstrate improvement in all three measures of nutrition knowledge. Further, this 
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study used quantitative and qualitative methods to gain patient feedback on the intervention in 
order to inform next steps for the clinic’s educational program. 
All procedures were approved by the University of North Carolina Office of Human 
Research Ethics and the Peking University Biomedical Institutional Review Board.  
Measures  
The primary outcome for this study was nutrition knowledge among T1D patients from 
the T1D clinic at the Peking University People’s Hospital. Two nutrition education surveys, 
referred to as the NKES 1 and NKES 2 surveys, were used to assess baseline nutrition 
knowledge pre-intervention and nutrition knowledge post-intervention.  The NKES 1 survey 
included sample demographic questions as well as nutrition knowledge questions assessing the 
three main nutrition knowledge measures: healthy diet, nutrition labels, and carbohydrate 
counting. These nutrition knowledge questions were translated and modified from the 3C 
Nutrition Ancillary Study Supplemental Questionnaire, the Nutrition Knowledge Survey (NKS), 
and the Heart Healthy Carb Quiz (HHCQ).9,71,72 The NKES 2 survey included these same 
nutrition knowledge questions as NKES 1, however this survey also included questions 
developed by collaborators of the study to evaluate patients’ feedback on the nutrition booklet. 
Two open-ended questions were included in this booklet evaluation section to allow patients to 
further elaborate their thoughts regarding what they favored most and least about the booklet.  
Lab measurements, including HbA1c, were assessed at baseline and were obtained 
through a medical record review performed by providers at the T1D clinic. More details of this 
medical record review are explained later in this section in “The Historical Control Phase.” 
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Participant Recruitment  
Participant recruitment for this study began in October 2017 and ended in April 2018. 
Patients from the Peking University People’s Hospital in Beijing, China were screened for 
eligibility before participating in the study. The eligibility criteria for the study was as follows:   
• Age 15 years or older 
• Non-pregnant  
• Diagnosed with type 1 diabetes by a certified doctorate specialist  
Researchers of the study assessed the eligibility of patients who were interested in joining the 
study by completing an eligibility and recruitment form. A total of 40 adults aged 18 years and 
older were recruited for the study as a convenience sample based on the implementation schedule 
of this pilot clinic. The patients were asked to complete a consent form to confirm their 
awareness of participation in the clinic program evaluation.  
The Historical Control Phase  
The Historical Control Phase involved retrospectively accessing previous patient lab 
measurements prior to the patient’s first clinical consultation at the T1D clinic. Once patients 
signed the consent form, the clinic physician accessed and recorded patients’ height, weight, 
blood pressure, HbA1c, and lipid profile. Lab measurements were collected from one year prior 
to the patient’s first consultation at the Diabetes clinic. Only the most recent lab measurements 
prior to the first consultation were collected during this phase. The data collected during the 
Historical Control Phase served as the patients’ baseline data for this study.  
Active Data Collection Phase  
The Active Data Collection Phase involved all patient data collected since the start of the 
patient’s first clinical visit consultation. This data included both NKES 1 and NKES 2 survey 
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data. Given the limited evaluation time of this study, patients were evaluated prior to receiving 
either one or two clinical consultations depending on time of recruitment.  
Prior to receiving the initial consultation, participants completed the NKES 1 survey on 
paper at the clinic, which assessed for patient’s baseline nutrition knowledge. Once NKES 1 
survey data and baseline lab measurements were collected, these paper forms were scanned and 
sent through a password protected file to collaborators at UNC-CH for data entry into REDCap 
Software. The NKES 2 survey was initially intended to be taken by participants following the 
second consultation visit, however, due to the low rates of in-person follow-up visits during the 
timeline of this program evaluation, the NKES 2 survey was administered online through 
Qualtrics Software approximately one month after participants’ first baseline visit but prior to 
their second clinic visit. Through Qualtrics, patients were able to take the NKES 2 survey 
remotely and more efficiently through their phone, computer, or other technology device. Since 
personal links can only be used by one user, a personal link to the surveys was created for each 
participant in order to prevent vast distribution of the link to non-participants. For this study, 
there was a total of 40 participants recruited and 23 follow-up responses.  
Data Analysis  
Data from the medical record review and both NKES surveys were entered onto RedCap 
Software and exported for analysis through Microsoft Excel 16.11.1 and SAS software 9.4. T-
tests for continuous variable for 2 independent samples were used to assess 1.) associations 
between past diabetes education and baseline mean HbA1c (Table 9), 2.) past carbohydrate 
counting education and baseline mean HbA1c (Table 9), 3.) baseline nutrition knowledge scores 
from each of the three measures of nutrition knowledge and baseline mean HbA1c (Table 10), 
and 4.) baseline nutrition knowledge scores between participants who did not follow-up versus 
  43 
nutrition knowledge scores of those who did follow-up (Table 13). There were 3 missing reports 
for HbA1c at baseline so analyses for Table 9 and Table 10 were only performed for 37 
participants.  A paired t-test for continuous variables was performed to assess a difference in the 
mean scores of nutrition knowledge of each of the three measures of nutrition assessment pre and 
post the nutrition education consultation among patients who followed-up and completed the 
NKES 2 survey (Table 12). Chi-square tests were performed to look at associations between 
participant BMI reported from the medical record review and baseline mean HbA1c 
(Supplementary Table, S1) and the association between residency and source of managing diet 
with T1D (Supplementary Table, S3).  
Results  
Sample Demographics  
The study sample consisted of 40 adults with type 1 diabetes who received diabetes care 
from the Peking University People’s Hospital in Beijing, China. The sample had a mean age of 
41.7±16.1 years. The sample consisted of 22 females and 18 males. Majority of the sample 
resided from an urban, as opposed to rural setting and had at most a college level education. The 
sample also included predominantly ‘single’ individuals with only 25.0% reporting being 
“married, engaged, or in a domestic partnership”. Less than half of participants (40.0%) reported 
knowledge of their most recent HbA1c or knowledge of the date of their last HbA1c 
measurement. Almost half of participants (47.5%) self-reported age of first T1D diagnosis to be 
30 years or older, with the mean self-reported age of first T1D diagnosis being 32.7±18.0 years. 
Further, 85.0% of the sample were in-patient and already hospitalized for diabetes complications, 
such as DKA or hyperglycemia. See Table 4 and Table 5 for more detailed sample 
characteristics.  
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Medical Record Review 
Based on the medical record review shown in Table 6, 65.0% participants in the study 
had a BMI less than 23. The mean BMI of the sample was 21.9±3.8. The review also showed a 
mean HbA1c of 9.9±2.3 with 42.5% of participants having an HbA1c 10.0% or higher. Systolic 
and diastolic blood pressures were both within the target ranges with mean values of 129.6 ±16.1 
15.3 and 78.5±11.2 mmHg, respectively. The mean triglycerides and total cholesterol levels were 
also at optimal levels with means of 98.0±55.3 mg/dL and 179.4±48.1 mg/dL, respectively. The 
mean HDL was borderline low at mean 50.3±14.7 mg/dL. The mean LDL was approximately 
114.9±38.5.  
Reported Past Diabetes, Meal Planning, and Carbohydrate Counting Education  
Approximately 53% participants reported having past T1D education (Table 7). Of those 
participants, 65% reported receiving this education from a health care provider (physician, nurse, 
or dietitian), while the remaining reported receiving education from family, friends, or other 
sources. About 53% of the participants had reported receiving a meal plan, while the remaining 
reported never being given a meal plan (Table 7). Of those who had received a meal plan, 
majority reported adhering to the meal plan for all 7 days in the past week. Further, majority of 
participants also reported receiving education on managing their diet with T1D from health care 
providers. However, some patients also reported receiving this education from the internet or 
from books/magazines. Approximately 83% of participants reported never receiving 
carbohydrate counting education and of those who did report CC education, 71% reported not 
using CC on a regular basis (Table 8).  
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There was no significance found when assessing associations between having received 
past diabetes education and baseline mean HbA1c or between having received past CC education 
and baseline mean HbA1c (Table 9).  
Nutrition Knowledge Assessment  
The mean nutrition knowledge scores at baseline (n=40) calculated out of 100% for 
Healthy Diet questions, Nutrition Food Label questions, and CC questions were 45.8±21.6, 
42.9±29.5, and 23.4±18.9, respectively (see Table 11). Among the 23 follow-up participants, 
there was an overall improving trend in all three assessments of nutrition knowledge (see Table 
12). However, there was only a significant difference between the scores pre- and post-
intervention for ‘Healthy Diet’ questions (p=0.02) and ‘Carbohydrate Counting’ questions 
(p=0.01) (see Table 12). When analyzing baseline scores of participants who did not follow up 
(n=17) with baseline scores of those who did follow up (n=23) for each of the three nutrition 
measures, only ‘Healthy Diet’ questions showed a significant difference between the baseline 
scores of the two samples (p=0.02) (see Table 13).  
There was also a significant difference between mean HbA1c among those who scored 
less than 50% on the Nutrition Label questions and those who scored 50% or higher on the 
Nutrition Label questions, with those scoring less than 50% having a higher HbA1c level (see 
Table 10). No other significant associations were found comparing baseline HbA1c and nutrition 
knowledge.    
Nutrition Booklet Evaluation  
Most participants (95.7%) reported the booklet was motivating in helping them manage 
their diet with their diabetes. Similarly, 91% of participants believed the booklet was overall easy 
to understand and 96% believed the illustrations in the booklet helped them understand the 
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information. Ultimately most participants reported they would recommend the booklet to other 
patients with T1D. Further, 74% of participants reported feeling ‘confident’ in reading and 
understanding nutrition labels after reviewing the booklet. Likewise, 65% reported confidence in 
adjusting insulin to the amount of food eaten. Overall, 70% of participants reported feeling 
confident in managing their diet with their diabetes after reading the booklet. See Table 14 for 
more details on patients’ feedback on the nutrition booklet.  
 Based on qualitative feedback from the open-ended questions on the NKES 2 survey, 
common themes written by participants in regards to the booklet was their new knowledge on 
carbohydrate sources and carbohydrate counting. One participant noted realizing “carbohydrates 
are not just from starchy foods, but other food groups as well, such as fruits, vegetables and dairy 
products.” Further, majority of participants were introduced to the concept of insulin to 
carbohydrate ratios for the first time. There was a common emphasis on now being able to “shift 
mindsets away from a fixed model of insulin treatment to a more flexible model.” One 
participant also noted now using a scale to practice measuring various food items. On the other 
hand, some participants reported the booklet was “not practical” for measuring foods specific to 
their diet or lifestyle. Other participants also reported difficulty fully grasping the concept of 
insulin to carbohydrate ratios.  
Discussion  
This study aimed to evaluate a pilot program nutritional education intervention at a T1D 
clinic at the Peking University People’s Hospital in Beijing, China.  The study explored whether 
implementation of this intervention may improve overall nutrition knowledge and disease 
management among Chinese patients with T1D. The overall findings suggest an improving trend 
in nutrition knowledge post-intervention in all three nutrition assessment topics including general 
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healthy diets, nutrition food labels, and carbohydrate counting. However, there was only 
statistical significance between scores pre- and post-intervention for ‘Healthy Diet’ (p=0.02) and 
‘Carbohydrate Counting’ questions (p=0.01). This result suggests patients may have found these 
two topics more helpful in the intervention towards their T1D care in comparison to the content 
on nutrition food labels.  However, the mean score at baseline for ‘Carbohydrate Counting’ 
questions was the lowest (23.4%) among the three assessment topics, which may also suggest 
more potential area of improvement. Patients overall demonstrated low pre-intervention scores 
below 60% among all three measures of nutrition assessment which reiterates findings from the 
preliminary study demonstrating a serious lack of general baseline nutrition knowledge among 
T1D patients in China. Further, while there is an overall lack of baseline knowledge, this study 
demonstrated a variation in baseline nutrition knowledge exists among patients. Results from 
Table 10 descriptively showed higher scores in all three measures of baseline nutrition 
knowledge among participants who followed-up (n=23) than baseline scores of those who did 
not follow-up (n=17). This distinction in follow-up visits may be explained by varying levels of 
motivation towards T1D management potentially driven by baseline nutrition knowledge. Thus, 
participants with higher baseline nutrition knowledge may have had more motivation to manage 
their T1D and therefore were more likely to follow up for their second visit than those who did 
not have as much baseline knowledge. This subtle variation in baseline nutrition knowledge 
suggests future modifications to this program to better match individuals to tools based on their 
baseline knowledge. This may require initial screening for level of baseline knowledge and the 
need to develop more educational resources that are tailored to different levels of knowledge.  
Additionally, majority of participants reported receiving past diabetes education and 
nutrition education from health care providers including physicians, dietitians, or nurses. This 
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result emphasizes the key educational role providers play in patients’ fundamental knowledge of 
concepts and skills necessary for managing their dietary intake with T1D. Therefore, ensuring 
patients have adequate access to these providers is an essential factor to consider when aiming to 
provide increased care for these patients. Future interventions should attempt to increase referrals 
to dietitians in order to further personalize nutrition strategies.  
Another important finding was the mean HbA1c of the sample, which was a notably high 
9.9%. Previous literature focused on Chinese patients with T1D have never had a mean quite this 
high.36 This mean value may be explained by the fact that many of these patients in the study 
were in-patient (n=34) and were already hospitalized for diabetes complications, such as DKA or 
hyperglycemia. It may also be possible that HbA1c is associated with poor nutrition knowledge. 
Table 10 demonstrated a statistically significant difference in baseline HbA1c such that those 
who scored less than 50% on Nutrition Label questions had a higher HbA1c than those who 
scored 50% or higher in this section. However, no significant associations were found between 
baseline HbA1c and the other two nutrition knowledge categories, nor baseline HbA1c and past 
nutrition education or CC education (Table 9). Future studies should collect more participant 
data and further investigate the associations of HbA1c at pre- and post-intervention time points 
with improvements in nutrition knowledge to better assess the physiological applicability of the 
nutrition educational intervention.  
 Finally, a descriptive analysis of patients’ perceptions of the booklet compared with 
changes in actual nutrition knowledge score in all three assessment topics suggested a positive 
association between those who improved their score in each topic and those who agreed with the 
following characteristics of the booklet: motivating, easy to understand, and contained helpful 
illustrations (Supplemental Table, S6A).  Further, based on this descriptive analysis, those who 
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showed an improved score in all three topics were more likely to recommend the booklet to other 
patients with T1D.   Given many participants also did not quite grasp a thorough understanding 
of the insulin to carb ratio, future modifications of the booklet should be made to include more 
detail on insulin to carb ratios. In addition, addressing the practicality of the booklet’s food 
measurements and guidelines further reiterates the need to tailor nutrition education specifically 
to each patient’s diet and personal lifestyle. This may mean more nutrition education resources 
and tools that better match each patient’s baseline knowledge. Further, this study suggests more 
time is required between the educator (in most cases the provider) and the patient in order to 
ensure patients fully comprehend the material.  It also essential for patients to be encouraged to 
follow-up with their provider in order to maintain goals and address any particular barriers.  
There are several limitations of this study including the small sample size at baseline, as 
well as the low number of follow-up responses, which minimized the power to detect effect. 
Further the study carries a low generalizability to all T1D patients, given patients in this study 
were all adults and only recruited from the Peking University People’s Hospital clinic. Further, 
majority of participants were in-patient and already hospitalized for diabetes complications, and 
therefore are not representative of the general T1D population in China or other populations. 
Response bias and social desirability bias may have also influenced patient responses, given also 
many of the questions were self-reported. Missing survey responses may also suggest possible 
fatigue bias where patients may have felt the length of the survey to be too long. Further no 
monetary incentives were used to motivate participants to complete the entirety of the surveys. 
Despite these limitations, however, the study’s strengths include collection of primary data using 
both quantitative and qualitative approaches. To our knowledge, this study is also the first 
evaluation of an evidence-based pilot T1D nutritional educational intervention in China. Further, 
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the development of the intervention and the nutrition booklet included the collaboration and 
expert knowledge of Chinese health care providers at the Peking University People’s Hospital.  
Conclusions  
The goal of this study was to investigate whether implementation of a pilot nutrition 
educational intervention may improve overall nutrition knowledge and T1D management among 
T1D patients in China. This study’s findings suggest the intervention may overall improve 
nutrition knowledge, however only differences between scores pre- and post-intervention were 
seen in the “Healthy Diet” and “Carbohydrate Counting” measures of nutrition knowledge. The 
purpose of this pilot study was overall to enable a more formally powered study in the future. 
Future studies regarding the intervention should include modifications to the booklet that include 
more detailed content on insulin to carb ratios. Further, future studies need to focus on 
implementation of a nutrition-specific intervention tailored to each patient’s personal lifestyle 
and diet in order to improve practicality of the booklet and the overall intervention. This may 
indicate a need for the development of various nutrition educational tools and resources that 
better match each patient’s baseline knowledge, rather than the use of one standard booklet. 
Finally, future studies should investigate HbA1c during at least two time-points pre/post 
intervention to explore the potential physiological applicability of the intervention and T1D 
treatment.  
 
 
 
 
 
 
 
           Table 4. Sociodemographic of Study Participants 
Variable Name Mean ± SD (Min-Max) or n (%)* 
Age  41.7 ± 16.1 (18.0-78.0)  
Sex  
   Male  18(45.0) 
   Female 22 (55.0) 
BMI**   21.7 ± 4.5 (16.3-41.4) 
   Underweight/Healthy weight (<23.0) 29 (72.5) 
   Overweight/Obese (≥23.0) 11 (27.5)  
Residence  
   Urban  31 (79.5) 
   Rural  8 (20.5) 
Marital Status  
   Single 30 (75.0) 
  Married, engaged, or in a domestic partnership 10 (25.0) 
Highest level of education   
   Primary school or below 3 (7.5) 
   Junior or Senior high school  9 (22.5) 
   College  25 (62.5)  
   Masters and/or higher  0 (0.0) 
   Vocational school 3 (7.5)  
Current Employment  
   Worker 2 (5.1) 
   Farmer 1 (2.6) 
   Technology 3 (7.7) 
   Management 8 (20.8) 
   Teacher 2 (5.1) 
   Business  2 (5.1) 
   Health Care 0 (0.0) 
   House keeping 2 (5.1) 
   Student  7 (18.0) 
   Retired 6 (15.4) 
   Unemployed 2 (5.1) 
   Other  4 (10.3)  
Participants (n, %) that know their most recent HbA1C  16 (40.0)  
Participants (n, %) that know the date of their last HbA1C  16 (40.0)  
                       *Data are means ± SD or % as indicated.  
                       ** BMI calculated based on self-reported Height and Weight, see Table XX for BMI based on medical record review 
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Table 5. Self-Reported Age of T1D Diagnosis and Patient Status  
 Mean ± SD (Min-Max) or n (%)  
Age of First T1D Diagnosis*  32.7 ± 18.0 (1.0-78.0) 
         < 10 years  3 (7.5) 
         10-19 years  5 (12.5) 
         20-29 years  8 (20.0) 
         30+ years  19 (47.5) 
Patient Status**  
        In-patient  34 (85.0)  
        Out-patient  6 (15.0)  
* Data is self-reported and are means ± SD or % as indicated; n=35, 5 missing / ** n=40, no missing 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Medical Record Review at Baseline (n=40)    
Lab Measurement  Mean ± SD (Min-Max) or n (%) Target Ranges % Target Met 
HbA1c (%)* 9.9 ± 2.3 (6.1-16.5) < 7.5  
      < 7.5  4 (10.0)    
      7.5-9.9  16 (40.0)   10.8 
      10.0+  17 (42.5)    
Systolic Blood Pressure (mmHg) 129.6 ± 15.3 (103.0-173.0) 120-140 75.0 
Diastolic Blood Pressure (mmHg) 78.5 ± 11.2 (55.0-106.0) 80-90 35.0 
BMI  21.9 ± 3.8 (13.7-32.5)   
       Healthy Weight/Underweight (<23.0)  26 (65.0)   
       Overweight/Obese (≥23.0)  14 (35.0)   
Triglycerides, mg/dL** 98.0 ± 55.3 (42.5-315.3) < 150: Optimal 
150-199: Borderline high  
200+: High  
87.2 
Total Cholesterol, mg/dL** 179.4 ± 48.1 (113.7-336.8) < 200: Optimal  
200-239: Borderline high 
240 +: High 
84.6 
HDL, mg/dL** 50.3 ± 14.7 (28.2-92.4) ≥ 60: Optimal (associated with 
low risk of heart disease) 
41-59: Borderline low 
< 40: Too low (major risk factor 
for heart disease) 
25.6 
LDL, mg/dL** 
 
114.9 ± 38.5 (69.2-241.3) < 100: Optimal 
100-129: Acceptable (people with 
no health issues, but may be of 
concern for those with heart 
disease) 
130-159: Borderline High 
160-189: High 
35.9 
*n=37, 3 missing responses / ** n= 39, 1 missing response    
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Table 7. Patient Past Diabetes and Meal Planning Education (n=40) 
Variable n (%) 
Past Diabetes Education 
Yes 21 (52.5) 
No 17 (42.5) 
Don’t Know 2 (5.1) 
Source of T1D Education (“Choose All that Apply”) * 
Physician 17 (42.5) 
Nurse 4 (10.0) 
Dietitian 5 (12.5) 
Family 1 (2.5) 
Friends 2 (5.0) 
Other 1 (2.5) 
Given Meal Plan**  
Yes 20 (52.6) 
No 18 (47.4) 
Adherence to Meal Plan in the Past 7 Days***  
0 Days 2 (5.0) 
1 Days 0 (0.0) 
2 Days 0 (0.0) 
3 Days 1 (2.5) 
4 Days 1 (2.5) 
5 Days 2 (5.0) 
6 Days 1 (2.5) 
7 Days 12 (30.0) 
Source of Education on Managing Diet with T1D (“Choose 
All that Apply”)  
Physician 20 (50.0) 
Nurse 13 (32.5) 
Dietitian 16 (40.0) 
Family/Friend 4 (10.0) 
Internet/Web 13 (32.5) 
Book/Magazines 11 (27.5) 
Other 2 (5.0) 
* “Source of T1D Education” is contingent on “Past Diabetes Education” 
** n=38, 2 missing 
*** “Adherence to Meal Plan in the Past 7 Days” is contingent on “Given Meal Plan” 
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Table 8. Patient Past Carbohydrate Counting (CC) Education     
Variable  n (%)  
Past CC Education   
      Yes   7 (17.5) 
      No   33 (82.5) 
Frequency of CC Education* 
      1-2 times     5 (71.4)  
      3-5 times    1 (14.3)  
      6-10 times     0 (0.0  
      More than 10 times     1 (14.3)   
Use CC on Regular Basis? *    
     Yes    2 (28.6) 
     No    8 (71.4) 
Reason for CC*    
     Weight loss/maintenance   2 (28.6)  
     To adjust insulin dose   1 (14.3) 
     Consistent carb diet   5 (71.4) 
     Doctor prescribed   1 (14.3)  
     Other    0 (0.0) 
Method of CC*   
     Count grams   2 (28.6)  
     Exchange system   3 (42.9)  
     Rate method    0 (0.0)  
     Count 15 g carb choices   0 (0.0) 
     Count 10 g carb choices   0 (0.0)   
     Other    2 (28.6)   
* Data contingent only for participants who reported receiving past CC education (n=7)  
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                  Table 9. Received Past Diabetes and CC Education vs. Baseline Mean HbA1c*  
Received Past Diabetes Education** Baseline HbA1c (Mean % ± SD) P  
Yes 9.7 ± 1.9  0.51   
No 10.2 ± 2.7   
Received Past CC 
Education Baseline HbA1c (Mean % ± SD) P  
Yes 8.6 ± 1.5  0.18    
No 10.1 ± 2.4   
                    * n=37, 3 missing HbA1C, P£0.05 is considered statistically significant,  
                    **Response ‘No’ classified from ‘No’ and ‘Don’t know’  
 
 
 
 
                Table 10.  Baseline Nutrition Knowledge Score vs. Baseline Mean HbA1c*  
Healthy Diet Score Baseline HbA1c (Mean % ± SD) P  
< 50%  10.4 ± 2.4  0.30    
³ 50% 9.6 ± 2.2   
Nutrition Label Score  Baseline HbA1c (Mean % ± SD) P  
< 50% 10.6 ± 2.3 0.02  
³ 50% 8.9 ± 1.9  
CC Score  Baseline HbA1c (Mean % ± SD) P  
< 30% 9.9 ± 2.1 0.99  
³ 30% 9.9 ± 2.9   
                    * n=37, 3 missing HbA1C, P£0.05 is considered statistically significant,  
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Table 11. Pre-Intervention Mean Scores of Nutrition Knowledge  (n=40)  
Nutrition Knowledge  Pre-Intervention Score (Mean % ± SD) 
Healthy Diet Questions 45.8 ± 21.6 
Nutrition Food Label Questions 42.9 ± 29.5 
Carbohydrate Counting Questions  23.4 ± 18.9 
 
 
Table 12. Mean Scores of Nutrition Knowledge Pre/Post Nutrition Education Consultation, n=23 (only participants who followed-up)   
 
 Nutrition Score Pre/Post Nutrition Consultation  
Nutrition Knowledge  
Pre-Intervention Score (Mean 
% ± SD) 
Post-Intervention Score 
(Mean%  ± SD) P* 
Healthy Diet Questions 52.5 ± 18.7 59.8 ± 19.6 0.02 
Nutrition Food Label Questions 49.1 ± 27.5 61.5 ± 26.4 0.06 
Carbohydrate Counting Questions  26.7 ± 16.1 40.0 ± 22.6 0.01 
*P values are from paired t-test for continuous variables. P£0.05 is considered a statistically significant difference between the pre-test  
and post-test. 
 
 
Table 13. NKES 1 Mean Scores of Participants Who Did Not Follow up vs. Mean Scores of Only Participants Who Followed-Up*  
Nutrition Knowledge Non-Follow-up Baseline (NKES 1)  
Mean Scores (%) (n=17) 
Follow-up Baseline (NKES 1) 
Mean Scores (%) (n=23) 
P*   
Healthy Diet 36.8 ± 22.4 52.5 ± 18.7 0.02 
Nutrition Label 34.5 ± 30.7 49.1 ± 27.5 0.12 
Carb Counting 19.0 ± 21.8 26.7 ± 16.1 0.21 
*P£0.05 is considered a statistically significant difference between the two samples  
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          Table 14. Nutrition Booklet Evaluation (n=23) *   
 
 
 
 
 
 
 
 
 
* Responses classified: “Strongly Agree”/ “Somewhat Agree” classified to “Agree” and “Disagree”/ “Strongly Disagree” classified to “Disagree”  
Responses classified: “Extremely Confident”/“Confident” classified to “Confident” and “Slightly Confident”/ “Not Confident” classifed to “Not Confident”  
Statements   n (%)  
 
This booklet motivated me to manage my diet with my diabetes.  
       Agree 22 (95.7) 
       Disagree 1 (4.3)  
This booklet was overall easy to understand.  
       Agree 21 (91.3) 
       Disagree 2 (8.7) 
The illustrations in the booklet helped me understand the information.  
       Agree 22 (95.7) 
       Disagree 1 (4.3)  
I would recommend this booklet to other patients with type 1 diabetes.  
       Agree 22 (95.7) 
       Disagree 1 (4.3)  
After reading this brochure, my level of confidence in reading and understanding nutrition labels is:  
       Confident 17 (73.9) 
       Not Confident 6 (26.1)  
After reading this brochure, my level of confidence in adjusting my insulin to the amount of food I eat is:  
       Confident 15 (65.2) 
       Not Confident  8 (34.8)  
After reading this brochure, my overall level of confidence in managing my diet with my diabetes is:  
       Confident 16 (69.6) 
       Not Confident  7 (30.4)  
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APPENDIX: SUPPLEMENTARY TABLES 
  
 
S1. BMI status vs. Baseline HbA1C*  
 BMI Status   
HbA1C (%) 
Healthy/Underweight 
(BMI <23.0) 
Overweight/Obese 
(BMI >23.0) Total 
< 7.5  2 (5.4) 2 (5.4) 4 (10.8) 
7.5-9.9 11 (29.7) 5 (13.5) 16 (43.2) 
10.0 +  12 (32.4) 5 (13.5) 17 (45.9) 
Total  25 (67.6) 12 (32.4) 37 (100.0) 
* n=37, 3 missing, Chi-squared test p=0.7, P£0.05 is considered statistically significant 
 
 
 
         S2. Received Past Diabetes Education vs. Given Meal Plan*  
              Given Meal Plan 
Received Diabetes Education  Yes  No  Total  
Yes  14 (70.0) 7 (38.9)  21 (55.3) 
**No  6 (30.0)  11 (61.1) 17 (44.7)  
Total  20 (100.0) 18 (100.0) 38 (100.0) 
          * n=38, 2 missing, **Response ‘No’ classified from ‘No’ and ‘Don’t know’ 
 
 
 
 
S3. Residence vs. Source of Managing Diet with Diabetes, n (%)*  
 Source of Managing Diet with Diabetes 
Residence  
Health Care Provider 
(Physician, Nurse, 
Dietitian) 
Non-Provider 
(family/friend, internet, 
books) No Sources Total 
Urban  20 (51.3) 6 (15.4)  5 (12.8) 31 (79.5) 
Rural  6 (15.4)  2 (5.1) 0 (0.0)  8 (7.7) 
Total  26 (66.7) 8 (20.5)  5 (12.8)  39 (100.0)  
*n=39, 1 missing, Chi-Square test p=0.5, P£0.05 is considered statistically significant 
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           S4. Highest Level of General Education vs. Received Past Diabetes Education, n (%)  
 
 
 
 
 
 
 
 
 
 
 
 
                *Response ‘No’ classified from ‘No’ and ‘Don’t know’  
 
 
 
S5. Changes in Nutrition Knowledge Score Post Nutrition Education Consultation (n=23), n (%)  
  Nutrition Knowledge Questions 
Nutrition Score Change  Healthy Diet Questions  
Nutrition Food Label 
Questions  
Carbohydrate Counting 
Questions  
Number of participants 
with improved score (%)  14 (60.9) 14 (60.9) 17 (73.9) 
Number of participants 
with unchanged score (%)  4 (17.4) 6 (26.1) 0 (0) 
Number of participants 
with worse score (%)  5 (21.7) 3 (13.0) 6 (26.1) 
 
 
 Received Past Diabetes Education  
Highest Level of 
Education  Yes  No*   Total  
College  17 (68.0)  8 (32.0)  25 (100.0) 
Junior or Senior High 
School 3 (33.3)   6 (66.7)  9 (100.0)  
Primary School or 
below  0 (0.0)  3 (100.0)  3 (100.0)  
Vocational School  1 (33.3)  2 (66.7)  3 (100.0)  
Total  21 (52.5)  19 (47.5)  40 (100.0)  
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S6b Nutrition Knowledge Score Change vs. Booklet Evaluation Confidence (n=23) 
 
 
2a=After reading this booklet, 
my level of confidence in 
reading and understanding 
nutrition labels is: 
2b=After reading this booklet, 
my level of confidence in 
adjusting my insulin to the 
amount of food I eat is: 
2c=After reading this booklet, 
my overall level of confidence in 
managing my diet with my 
diabetes is:    
Confident  Not Confident Confident  Not Confident Confident  Not Confident 
Healthy Diet Questions  
      
% of participants with improved score 11 (47.8) 3 (13.0) 12 (52.2) 2 (8.7) 12 (52.2) 2 (8.7) 
% of participants with unchanged or worse score 6 (26.1) 3 (13.0) 3 (13.0) 6 (26.1) 4 (17.4) 5 (21.7) 
Nutrition Label Questions       
% of participants with improved score 11 (47.8) 3 (13.0) 11 (47.8) 3 (13.0) 10 (43.5) 4 (17.4) 
% of participants with unchanged or worse score 6 (26.1) 3 (13.0) 4 (17.4) 5 (21.7) 6 (26.1) 3 (13.0) 
Carb Counting Questions       
% of participants with improved score 12 (52.2) 5 (21.7) 11 (47.8) 6 (26.1) 12 (52.2) 5 (21.7) 
% of participants with unchanged or worse score 5 (21.7) 1 (4.4) 4 (17.4) 2 (8.7) 4 (17.4) 2 (8.7) 
       
       
 
 
S6a Nutrition Knowledge Score Change vs. Booklet Evaluation (n=23)     
 
1a=This booklet 
motivated me to 
manage my diet 
with my diabetes 
1b=This booklet 
was overall easy to 
understand. 
1c=The 
illustrations in the 
booklet helped me 
understand the 
information  
1d=I would 
recommend this 
booklet to other 
patients with type-
1 diabetes 
 Agree  Disagree Agree  Disagree Agree  Disagree Agree  Disagree 
Healthy Diet Questions          
% of participants with improved score  13 (56.5) 1 (4.4) 14 (60.9) 0 (0.0) 13 (56.5) 1 (4.4) 13 (56.5) 1 (4.4) 
% of participants with unchanged or worse score 9 (39.1) 0 (0.0) 7 (30.4) 2 (8.7) 9 (39.1) 0 (0.0) 9 (39.1) 0 (0.0) 
Nutrition Label Questions          
% of participants with improved score  13 (56.5) 1 (4.4) 13 (56.5) 1 (4.4) 13 (56.5) 1 (4.4) 13 (56.5) 1 (4.4) 
% of participants with unchanged or worse score 9 (39.1) 0 (0.0) 8 (34.8) 1 (4.4) 9 (39.1) 0 (0.0) 9 (39.1) 0 (0.0) 
Carb Counting Questions          
% of participants with improved score  16 (69.6) 1 (4.4) 15 (65.2) 2 (8.7) 16 (69.6) 1 (4.4) 16 (69.6) 1 (4.4) 
% of participants with unchanged or worse score 6 (26.1) 0 (0.0) 6 (26.1) 0 (0.0) 6 (26.1) 0 (0.0) 6 (26.1) 0 (0.0) 
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S7. HbA1C of Participants Who Reported Adhering to Meal for 7 Days* 
HbA1C (%) n 
< 7.5 0 
7.5-8.9 3 
9.0-9.9 2 
10.0-11.9 2 
12.0+ 4 
* n=11, 1 missing   
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